Sovipostobart Biosimilar - Research Grade

Human

CTLA4ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P09793;P16410

Blue ice

CTLA-4 is an inhibitory checkpoint receptor that downregulates early T-cell activation and is a central target in cancer-immunology research. The product here is a research-grade, unconjugated analog of sovipostobart, a recombinant anti-CTLA-4 monoclonal antibody for research use only. Manufactured to in vivo standards with low endotoxin, it is provided in scalable milligram to gram quantities to support bulk and high-throughput laboratories. It functions as a control and active reagent in checkpoint-blockade functional assays, in vitro T-cell activation screens, and in vivo immune-modulation models. Dependable lot-to-lot consistency underpins reliable use across large and repeated experiments.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks